Skip to main content

Table 2 Aspergillus spp. isolates per year according to clinical settings and relative incidence

From: Hospital distribution, seasonality, time trends and antifungal susceptibility profiles of all Aspergillus species isolated from clinical samples from 2015 to 2022 in a tertiary care hospital

 

N° of isolates

Setting

Aspergillus species

2015

2016

2017

2018

2019

2020

2021

2022

overall

Internal medicine

A. fumigatus

22

24

18

25

29

18

11

22

169

A. niger

8

14

6

6

10

2

4

8

58

A. flavus

8

9

6

10

6

2

5

12

58

A. terreus

3

7

5

3

5

1

4

8

6

others

1

0

0

4

2

0

3

2

12

Surgery

A. fumigatus

4

12

3

4

3

2

2

5

35

A. niger

3

5

3

3

4

2

3

2

25

A. flavus

2

2

1

2

3

0

4

2

16

A. terreus

0

1

0

0

2

0

1

0

4

others

1

0

0

1

1

0

2

3

8

ICU

A. fumigatus

9

45

13

13

10

12

23

28

123

A. niger

2

5

4

5

5

4

24

17

66

A. flavus

7

6

6

9

8

4

10

16

66

A. terreus

5

5

9

6

6

1

8

14

54

others

1

1

4

0

1

1

3

2

13

Outpatient clinic

A. fumigatus

17

19

19

22

23

14

28

28

170

A. niger

12

15

13

13

6

6

14

23

102

A. flavus

2

3

8

15

5

5

5

16

59

A. terreus

1

7

0

6

5

0

4

2

25

others

0

1

1

0

4

4

10

7

27

Incidence for 10,000 patient-day

A. fumigatus

1.76

2.32

1.74

2.12

2.19

1.73

2.28

N/Aa

 

A. niger

0.81

1.29

0.85

0.89

0.84

0.53

1.60

N/A

 

A. flavus

0.64

0.66

0,69

1.19

0.74

0.37

0.85

N/A

 

A. terreus

0.27

0.66

0.46

0.50

0.61

0.08

0.61

N/A

 

others

0.10

0.07

0.16

0.17

0.27

0.19

0.64

N/A

 

Overall

3.58

5.00

3.90

4.87

4.66

2.89

5.98

N/A

 
  1. aData regarding 2022 patient-day have not been published yet